Antibiotics market Share, Growth Analysis by 2035
Clinical trials have demonstrated the enormous benefits offered by novel antibiotics for the treatment of a wide range of infections, presenting lucrative opportunities for the players engaged in the development of these therapies.
Driven by the extensive R&D efforts of both industry and non-industry players, along with the growing demand for effective antibiotic therapies, the global antibiotic market is anticipated to witness steady growth over the next decade.
The financial opportunity within the global antibiotics market has been analyzed across the following segments:
Type of Drug Class
Tetracyclines
Aminoglycosides
Lincosamides
Carbapenems
Lipoglycopeptides
Cephalosporins
Fluoroquinolones
Triazaacenaphthylenes
Other Drug Classes
Mechanism of Action
Protein Synthesis Inhibition
Cell Wall Synthesis Inhibition
Nucleic Acid Synthesis Inhibition
DNA Synthesis Inhibition
Mycolic Acid Synthesis Inhibition
Nature of Source
Semi-synthetic
Synthetic
Target Disease Indication
Respiratory Tract Infections
Dermatological Infections
Urinary Tract Infections
Sexually Transmitted Infections
Gastrointestinal Infections
Hematological Infections
Ear Infections
Cystitis
Diabetic Foot Infections
Other Bacterial Infections
Type of Therapy
Monotherapies
Combination Therapies
Route of Administration
Intravenous
Oral
Intravenous / Oral
Key Geographical Regions
North America
Europe
Asia Pacific
MENA
Latin America
The research includes profiles of the key players (listed below) engaged in this domain; each profile features a brief overview of the company, details on buffer manufacturing systems and services, recent developments and an informed future outlook.
Bristol Myers Squibb
Daiichi Sankyo
GlaxoSmithKline
Melinta Therapeutics
Merck
Pfizer
Table of Contents
1. Executive Summary
2. Introduction
3. Market Landscape: Approved Antibiotic Generics
4. Market Landscape: Approved Antibiotic Brands
5. Market Landscape: Clinical-Stage Antibiotics
6. Company Profiles
7. Partnerships And Collaborations Analysis
8. Clinical Trial Analysis
9. Key Opinion Leaders
10. Key Trends in Antibiotics Industry
11. Approved Antibiotics: Success Protocol Analysis
12. Market Forecast and Opportunity Analysis
13. Appendix I: Tabulated Data
14. Appendix II: List of Companies and Organizations
Key Questions Answered
Who are the leading players involved in the development of antibiotics?
Which popular therapeutic areas are being targeted by clinical-stage antibiotics?
What is the focus area of the ongoing research activity in the antibiotics domain?
What types of partnership models are commonly adopted by stakeholders in this industry?
What are the crucial factors that impact the sales of antibiotics?
Who are the major key opinion leaders in the antibiotics domain?
What are the key market trends and driving factors that are likely to impact this market?
What is the current / likely future global antibiotics market size?
Which drug class accounts for the largest share within the antibiotics market?
Which region captures the largest share of the antibiotics market?
To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/global-antib
News article
Global Gene Switch Market
Learn from experts: do you know about these emerging industry trends?
Rare Kidney Disorders: Future Miracle Drugs
Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#multidrugresistantbacteria #antimicrobialresistance #amoxicillinshortage #marketresearch #marketinsights
